Nephrocalcinosis: new insights into mechanisms and consequences.
about
NADPH oxidase as a therapeutic target for oxalate induced injury in kidneysAssociation of pretransplant serum phosphorus with posttransplant outcomes.Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.Genetic modulation of nephrocalcinosis in mouse models of ectopic mineralization: the Abcc6(tm1Jfk) and Enpp1(asj) mutant miceLaterality of nephrocalcinosis in kidney stone formers with severe hypocitraturiaTransplantation outcomes in primary hyperoxaluria.Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.Spontaneous calcification process in primary renal cells from a medullary sponge kidney patient harbouring a GDNF mutation.Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.Successful treatment of early allograft dysfunction with cinacalcet in a patient with nephrocalcinosis caused by severe hyperparathyroidism: a case report.1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.Ultrastructural investigation of crystal deposits in Npt2a knockout mice: are they similar to human Randall's plaques?A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.Mechanisms of human kidney stone formation.Crystal nephropathies: mechanisms of crystal-induced kidney injury.The effect of intracrystalline and surface-bound osteopontin on the attachment of calcium oxalate dihydrate crystals to Madin-Darby canine kidney (MDCK) cells in ultrafiltered human urine.Progressive renal insufficiency, hypercalcaemia, bicytopaenia and a history of breast cancer.Kidney allograft failure due to acute phosphate nephropathy associated with severe secondary hyperparathyroidismRevisiting nephrocalcinosis: A single-centre perspective. A northern Italian experience.Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.Crystalluric and tubular epithelial parameters during the onset of intratubular nephrocalcinosis: illustration of the 'fixed particle' theory in vivo.NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy.Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial.Caspase-independent programmed cell death triggers Ca2PO4 deposition in an in vitro model of nephrocalcinosis.Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats.Translocation of mineralo-organic nanoparticles from blood to urine: a new mechanism for the formation of kidney stones?Medullary nephrocalcinosis in Schimke immuno-osseous dysplasia.Familial autosomal recessive renal tubular acidosis: importance of early diagnosis.
P2860
Q27014373-54D15C8A-C8AE-4A09-ADAE-38E5182B4C99Q30424192-B4890FE9-DEE7-46A0-8479-542D6499FF97Q33582212-C75084EC-85D9-4F57-A59F-45C8FB9B96A7Q33690527-8C390C93-A7FA-4E7E-AF49-B16C5F82D37FQ34193653-850871E6-76BC-44FE-B349-E9A1F66F33B6Q34247162-3BD93D45-C6F8-4220-95D9-AA651CE4AD51Q34405366-7EFB6E5E-77F9-4D91-A410-7BDE48657AB1Q34848951-03A90A0B-608C-48F3-92AD-D2487DF4EDDEQ35391129-051B0BCE-4656-4D52-890B-E5D4D6F7A658Q35978549-7EDDFE6A-81E3-46CC-8192-E43C226F953DQ36341001-02D4281B-F07A-467E-840E-DC84C8178929Q36733570-4F58F7CA-09D6-4741-82CC-240AC819066BQ36764508-39ECA531-975C-42F7-AFFD-58896E343CFBQ37439745-0AAD6636-15C8-4544-8BC9-B51034CC1115Q38238445-99CE649F-3546-4853-81F2-211D4FF4AF8DQ39144172-7818E703-1C37-4A57-8AE4-B225562CC7EBQ39480917-92CC3EC9-917F-4EAE-ACE0-C68CBDDF4F36Q40336532-CE2DC05B-F6D8-4538-BC81-6C1D0F8434A8Q40339598-23625789-605D-4BFC-B2D8-53DC1060553CQ40853063-3F657A2E-3553-4BE8-ABFE-6DFAF60DA29EQ41919477-C5C62200-AA2C-4A5F-AF20-E2F1F7A6A9E6Q43283550-6A2A1C2C-7AC7-4EE8-B1CF-2182B75A91C5Q44679349-8825CDC4-BC61-4072-B130-C5A380A38859Q44899453-12EC7B4C-AE55-4E6C-A769-10864AD4B082Q49166943-CA5A5559-7A9E-4021-84C9-2ED14BF2D2B9Q49584411-23B02057-A3DA-4F05-A6DF-96C1B4B3A2CBQ51212310-35C8835B-8503-43C0-856A-786196CAA064Q53546738-EE80931A-BE97-4A65-B131-5BCB0B4B6D07Q54353488-6BD41E3E-928D-4507-9B74-88881C32B00E
P2860
Nephrocalcinosis: new insights into mechanisms and consequences.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nephrocalcinosis: new insights into mechanisms and consequences.
@en
Nephrocalcinosis: new insights into mechanisms and consequences.
@nl
type
label
Nephrocalcinosis: new insights into mechanisms and consequences.
@en
Nephrocalcinosis: new insights into mechanisms and consequences.
@nl
prefLabel
Nephrocalcinosis: new insights into mechanisms and consequences.
@en
Nephrocalcinosis: new insights into mechanisms and consequences.
@nl
P2093
P356
P1476
Nephrocalcinosis: new insights into mechanisms and consequences.
@en
P2093
Anja Verhulst
Benjamin A Vervaet
Marc E De Broe
Patrick C D'Haese
P304
P356
10.1093/NDT/GFP115
P407
P577
2009-03-18T00:00:00Z